Drugs / 99mTc-DARPinG3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05376644 | May → Dec 2022 | female breast carcinoma | Tomsk National Research Medical Center of the Russian Academy of Sciences | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTc-DARPinG3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05376644 ↗ |